Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 18, 2020
Ultragenyx Pharmaceutical and Mereo BioPharma Group announced a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta.
read more
Friday, December 18, 2020
Vectura has announced its partner Hikma has launched its generic version of GlaxoSmithKline’s Advair Diskus, 100mcg/50mcg and 250mcg/50mcg doses, in the US.
read more
Thursday, December 17, 2020
Aeterna Zentaris has entered into a licensing agreement with Consilient Health for the commercialization in Europe and the United Kingdom of macimorelin.
read more
Friday, December 11, 2020
Viatris has expanded on the restructuring program announced by Mylan earlier this year.
read more
Thursday, December 10, 2020
LIPAC Oncology and Huons announced the achievement of a development milestone in their partnering agreement by finalizing its Clinical Study Report for a Phase 2A marker lesion clinical trial in patients with low-grade highly recurrent NMIBC treated ...
read more
Tuesday, December 08, 2020
Piramal Pharma Limited has announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of APIs.
read more
Monday, December 07, 2020
Fresenius Kabi USA is voluntarily recalling a single lot of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg /mL), 50 mL fill in a 50 mL vial.
read more
Thursday, December 03, 2020
Samsung Bioepis and Biogen announced the FDA has accepted for review the BLA for SB11, a proposed biosimilar referencing Lucentis.
read more
Wednesday, December 02, 2020
Pfizer and BioNTech announced the MHRA in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine against COVID-19.
read more
Wednesday, December 02, 2020
Lonza has announced additional investments in its oral drug product development and manufacturing capabilities at its Tampa, Florida site.
read more
Tuesday, December 01, 2020
Mustang Bio and Minaris have signed an agreement to enable technology transfer and GMP clinical manufacturing of Mustang’s MB-107 lentiviral gene therapy program for the treatment of XSCID in Europe.
read more
Monday, November 30, 2020
Allos Pharma has announced the exclusive license rights on arbaclofen in Fragile X Syndrome.
read more
Wednesday, November 25, 2020
Aeterna Zentaris has entered into an amendment of its existing License Agreement with NNBL related to the development and commercialization of macimorelin.
read more
Monday, November 23, 2020
Onyx Scientific announced it is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license.
read more
Monday, November 23, 2020
Humanigen announced the company and the DoD have entered into a CRADA in collaboration with the BARDA in support of Operation Warp Speed to assist in the development of lenzilumab as a potential COVID-19 treatment.
read more